Database: Netherlands Cancer Registry (NKR) (The Netherlands): Difference between revisions

From Beacon
(Created page with "{{#subobject:Netherlands Cancer Registry (NKR) |dct:title=Netherlands Cancer Registry (NKR) |datatype=registry }} [https://iknl.nl/nkr/over-nkr] [https://iknl.nl/nkr/uitleg-nkr-cijfers] '''Primary purpose:''' Registry and monitor cancer statistics around the Netherlands. '''Sponsor, manager or home institution''': Comprehensive Cancer Center of the Netherlands (IKNL). '''Type of information''': The type of information available to each type of cancer at patient lev...")
 
No edit summary
Line 1: Line 1:
{{#subobject:Netherlands Cancer Registry (NKR)
|dct:title=Netherlands Cancer Registry (NKR)
|datatype=registry
}}
[https://iknl.nl/nkr/over-nkr] [https://iknl.nl/nkr/uitleg-nkr-cijfers]
[https://iknl.nl/nkr/over-nkr] [https://iknl.nl/nkr/uitleg-nkr-cijfers]


'''Primary purpose:''' Registry and monitor cancer statistics around the Netherlands.
'''Primary purpose:''' Registry and monitor cancer statistics around the Netherlands.


'''Sponsor, manager or home institution''': Comprehensive Cancer Center of the Netherlands (IKNL).
'''Sponsor, manager or home institution''': [[dataOwner::Comprehensive Cancer Center of the Netherlands (IKNL)]].


'''Type of information''': The type of information available to each type of cancer at patient level [https://iknl.nl/nkr/registratie/itemsets] and type of treatment given.
'''Type of information''': The type of information available to each type of cancer at the patient level [https://iknl.nl/nkr/registratie/itemsets] and type of treatment given.


'''Available type of information''': Incidence; Count, crude rate per 100,000 persons per year; European Standardized Rate (ESR) per 100,000 persons per year; World Standardized Rate (WSR); Revised European Standardized Rate (RESR); Type of cancer; Gender; Age; Region; Year; Prevalence; Mortality; Survival: relative survival; Period from diagnosis (1 year and 10 years); Age at time of diagnosis; Stage at time of diagnosis (TNM).
'''Available type of information''': [[availableVariable::cancer incidence]]; Count, [[availableVariable::crude rate]] per 100,000 persons per year; [[availableVariable::European Standardized Rate (ESR)]] per 100,000 persons per year; [[availableVariable::World Standardized Rate (WSR)]]; Revised European Standardized Rate (RESR); [[availableVariable::Type of cancer]]; [[availableVariable::Sex]]; [[availableVariable::Age]]; [[availableVariable::Region]]; [[availableVariable::Year]]; [[availableVariable::cancer prevalence]]; [[availableVariable::cancer mortality]]; [[availableVariable::cancer survival]]; [[availableVariable::relative survival]]; [[availableVariable::period from diagnosis]]; (1 year and 10 years); [[availableVariable::age at time of diagnosis]]; [[availableVariable::stage of tumor at time of diagnosis (TNM)]].


Also, there is a cancer atlas that informs of the incidence of cancer in each region of the Netherlands in the period of 2011–2020 and compares it to the Dutch average. This information can be selected by type of cancer, region, and gender.
Also, there is a cancer atlas that informs of the incidence of cancer in each region of the Netherlands in the period of 2011–2020 and compares it to the Dutch average. This information can be selected by type of cancer, region, and gender.
Line 18: Line 13:
'''Source of information''': Hospitals' reports.
'''Source of information''': Hospitals' reports.


'''Data level''': Patient level.
'''Data level''': [[dataLevel::patient level]].


'''Available data level''': Regional level.
'''Available data level''': [[availableDataLevel::regional level]].


'''Number of Records:''' Contains information about all new cases of malignant neoplasms and some benign neoplasms (tumors of the central nervous system, borderline tumors of the ovary, and AL amyloidosis) in the Netherlands.
'''Number of Records:''' Contains information about all new cases of malignant neoplasms and some benign neoplasms (tumors of the central nervous system, borderline tumors of the ovary, and AL amyloidosis) in the Netherlands.
Line 26: Line 21:
'''Date range''': Varies according to the diagnosis and the type of information [https://iknl.nl/nkr/registratie/itemsets].
'''Date range''': Varies according to the diagnosis and the type of information [https://iknl.nl/nkr/registratie/itemsets].


'''Cancer Areas of Interest:''' Regional data includes all invasive cancers except basal cell carcinoma of the skin.
'''Cancer Areas of Interest:''' Regional data includes [[hasCancerAreasList::all invasive cancers except basal cell carcinoma of the skin]].


'''Data access''': Partially publicly available [https://iknl.nl/nkr-cijfers]. Instructions to request data for restricted content [https://iknl.nl/nkr/cijfers-op-maat/gegevensaanvraag]. The cancer atlas access [https://kankeratlas.iknl.nl/].
'''Data access''': [[dataAvailability::Partially publicly available]] [https://iknl.nl/nkr-cijfers]. Instructions to request data for restricted content hasDataAccessInstructions::[https://iknl.nl/nkr/cijfers-op-maat/gegevensaanvraag]]]. The cancer atlas access [https://kankeratlas.iknl.nl/].


'''Contact information''': Information [https://iknl.nl/over-iknl/contact-adres].
'''Contact information''': Information [https://iknl.nl/over-iknl/contact-adres].

Revision as of 16:55, 15 November 2023

[1] [2]

Primary purpose: Registry and monitor cancer statistics around the Netherlands.

Sponsor, manager or home institution: Comprehensive Cancer Center of the Netherlands (IKNL).

Type of information: The type of information available to each type of cancer at the patient level [3] and type of treatment given.

Available type of information: cancer incidence; Count, crude rate per 100,000 persons per year; European Standardized Rate (ESR) per 100,000 persons per year; World Standardized Rate (WSR); Revised European Standardized Rate (RESR); Type of cancer; Sex; Age; Region; Year; cancer prevalence; cancer mortality; cancer survival; relative survival; period from diagnosis; (1 year and 10 years); age at time of diagnosis; stage of tumor at time of diagnosis (TNM).

Also, there is a cancer atlas that informs of the incidence of cancer in each region of the Netherlands in the period of 2011–2020 and compares it to the Dutch average. This information can be selected by type of cancer, region, and gender.

Source of information: Hospitals' reports.

Data level: patient level.

Available data level: regional level.

Number of Records: Contains information about all new cases of malignant neoplasms and some benign neoplasms (tumors of the central nervous system, borderline tumors of the ovary, and AL amyloidosis) in the Netherlands.

Date range: Varies according to the diagnosis and the type of information [4].

Cancer Areas of Interest: Regional data includes all invasive cancers except basal cell carcinoma of the skin.

Data access: Partially publicly available [5]. Instructions to request data for restricted content hasDataAccessInstructions::[6]]]. The cancer atlas access [7].

Contact information: Information [8].